Obesity and obesity-related disorders such as cardiovascular diseases and metabolic abnormalities including hypertension, hyperinsulinemia, insulin-resistance and type 2 diabetes, are among the most pressing problems in the industrialized world (Friedman, 2003; Kannel et al., 1991 (Reitman et al., 2000) , demonstrating that normal adipose tissue development and function is critical for metabolic homeostasis.
ISSN 1555-8932 print, Copyright © 2006 by New Century Health Publishers, LLC www.newcenturyhealthpublishers.com All rights of reproduction in any form reserved frequently predispose to the same medical conditions (Reitman et al., 2000) , demonstrating that normal adipose tissue development and function is critical for metabolic homeostasis.
Obesity results from complex interactions between genes and environmental factors such as diet, food components and/or way of life, and can be viewed as an energy storage disorder in which weight gain results from an energy imbalance (i.e. energy input exceeding output), with most of the excess calories stored as triglycerides in adipose tissue (Smith et al., 2006) . Therefore a great deal of attention has focused on the mechanisms controlling food intake and adipose mass, and is of considerable importance for public health and clinical medicine.
In this review, we prevalently highlight the complex relationships existing between the white adipose tissue, the central nervous system, the endogenous microbiota, and nutrition. Throughout, we emphasize the most recent findings in the field and consider how it shapes the past knowledge and forecasts the future of research on metabolic disorders, such as obesity.
I. Adipocytes, Genes and Nutrition.

I.1. Adipose tissue: adipocytes and macrophages.
The traditional view of adipose tissue has recently switched from a passive energy "reservoir" with insulatory attributes to a complex, highly active and essential metabolic and endocrine organ, churning out an assortment of hormones and other signals regulating the whole-body physiology (e.g. food intake, body weight and brain activity).
Adipose tissue consists of approximately one third of fat cells i.e. adipocytes, whereas the remaining 2/3 represent a combination of small blood vessels, connective tissue matrix, nerve tissue and stromal vascular cells; such as pre-adipocytes in various stages of development. All these components of the adipose tissue function as an integrated unit that allows fatty acid accumulation in adipocytes after a meal and fuel distribution to the entire organism between meals.
The formation of adipose cells from mesoderm begins from mid to late gestation. Adipose tissue is rapidly organized after birth as a result of increased size of existing fat cells and proliferation of precursor pre-adipocyte cells. Thereafter, new fat cells can be generated throughout life as a function of environmental factors, especially according to nutritional status (Faust et al., 1978; Faust et al., 1984; Miller et al., 1984; Fève 2005) .
Additionally, one key feature of adipose tissue is its endowment in striking plasticity properties exemplified by the dramatic anatomical changes of this tissue under nutritional stimuli. As we will evoke in a following section of this review, the size of the adipose tissue stores increases in period of positive energy balance and decreases when energy expenditure is in excess.
The expansion of adipose tissue mass and cellularity during obesity appears not restricted to the sole increase in number and size of adipocytes. In particular, a progressive infiltration by macrophages is observed in adipose tissue as obesity develops (Weisberg et al., 2003; . These accumulating macrophages are mainly responsible for the up-regulation of inflammatory-related genes observed in obese fat tissues, such as Tumor Necrosis Factor-alpha (TNF-a) or Interleukin-6 (IL-6) (Dandona et al., 1998; Bastard et al., 2000) , leading to the suggestion that adipose tissue in obesity is a pro-inflammatory condition, referred to as "obesitis" (Schmidt and Duncan, 2003) .
With the "obesity epidemic", the capacity to store energy has earned increasing notoriety for adipose tissue and consequently pushed the adipocyte into the limelight, leading to intensive researches in the cellular and molecular mechanisms underlying adipose tissue development and adipocyte formation. We will now review the main features of adipogenesis, with a special emphasis on gene expression during this dynamic process.
I.2. Adipocyte formation: the process of Adipogenesis.
The number of adipocytes present in an organism is determined to a large degree by the adipocyte differentiation process i.e. adipogenesis, which generates mature adipocytes from precursor cells. Basic adipocyte number is established by adolescence in both humans and rodents, although one retains the capacity to generate new adipocytes at all ages. Originally, adipose cells are derived from pluripotent stem cells during a process involving a complex communication network between several transcription factors, some of which being sensors for nutrients.
Most of the molecular details of adipogenesis are now known and have been exhaustively described. This differentiation programme cannot simply be viewed as a hierarchy of molecular events with a modulation in the expression of early, intermediate and late genes (Gregoire et al., 1998; Rangwala and Lazar, 2000; Rosen et al., 2000; Ntambi and Young-Cheul, 2000) . Instead, adipogenesis should be regarded as a continuum of overlapping molecular events under the tight control of many factors such as nutrients, finely regulating the sense and the magnitude of the adipose conversion process.
I.2.a: Transcriptional factors controlling adipogenesis.
The mechanisms of adipogenesis were first detailed using cloned pre-adipocyte lines having the potential for differentiation in culture, before being further supported by studies in transgenic mice. It showed that several pro-and anti-adipogenic transcription factors are involved in adipocyte differentiation (recently reviewed by Fève, 2005) .
First, adipogenesis is positively regulated by the coordinated expression and activation of several transcription factor families such as the CCAAT/enhancer binding protein (C/EBP), peroxisome proliferator-activated receptor (PPAR) and sterol regulatory element-binding protein-1c (SREBP-1c) families (recently reviewed by Rosen, 2005) .
Among members of the PPAR family, the "champion" of adipocyte differentiation is PPAR-γ (Lowell, 1999) . Mainly expressed in adipose tissue, PPAR-γ heterodimerizes with retinoid X receptor (RXR) and regulates transcription of target genes through binding to specific peroxisome proliferator response elements. The precise nature of endogenous PPAR-γ ligands is not yet clear, nevertheless various fatty acids, notably originating from nutrients, are able to activate PPAR-γ (Willson et al., 2001; Al-Hasani and Joost, 2005; Sampath and Ntambi, 2005) .
The key role of PPAR-γ in adipose conversion is reinforced by the observation that polymorphisms and mutations in PPARG, notably those resulting in production of transactivation-defective proteins, are linked to decreased adiposity in humans (Gurnell et al., 2003; Knouff and Auwerx, 2004) . Complementary, whereas total lack of PPAR-γ is embryonically lethal in mice (Barak et al., 1999; Kubota et al., 2003) , mouse models presenting reduced PPAR-γ activity in adipose tissue display a systemic reduction of fat pad mass (Kubota et al., 2003) . Similarly, targeted deletion of PPAR-γ activity in adipose tissue results in progressive loss of both subcutaneous and epididymal fat pads (Zhang et al., 2004) . These mouse models, and several others, strongly demonstrate that the levels of PPAR-γ expression in adipose tissue is essential in the determination of total body fat mass.
PPAR-γ is not the sole transcription factor that positively regulates adipocyte differentiation. Members of the C/EBP family (a, b, and d) and SREPB-1c are also significantly elevated during this process, although their expression is not exclusively restricted to adipose tissue. Despite being expressed relatively late during adipogenesis, the crucial role of C/EBP-a is clearly demonstrated in the knockout mouse that presents a major reduction in the lipid content of fat tissue (Wang et al., 1995) . Regarding C/EBPb and -d, their expression occurs very early during adipogenesis and is essential for the proper expression of PPAR-γ. Mice lacking both C/EBP-b and -d exhibit a decrease in adipose tissue development (Tanaka et al., 1997) .
Lastly, SREBP-1c both enhances adipose conversion by promoting PPAR-γ expression and activity (Kim et al., 1998; Fajas et al., 1999) and plays an essential role in the regulation of the two major lipid pathways leading to fatty acid storage in mature adipocytes.
Second, in addition to this positive transcriptional control of adipogenesis, some factors have been reported to negatively regulate this process. To name some but a few, two members of the GATA family of zinc finger transcription factors able to bind to a common (A/T)GATA(A/G) DNA consensus sequence: GATA-2 and GATA-3, exert an inhibitory effect on adipose conversion, likely through decreasing PPAR-γ promoter activity (Tong et al., 2000) . Similarly, mice overexpressing the forkhead transcription factor FOXC2 in adipose tissue are lean and more sensitive to insulin (Cederberg et al., 2001) .
I.2.b : Environmental factors controlling adipogenesis.
Numerous environmental factors such as hormones, cytokines or nutrients either promote or block the process of adipocyte differentiation.
Exemplifying the promoting factors, glucocorticoids (GCs) have been reported to be potent inducers of adipogenesis, mostly by activating the expression of both C/EBP-d and PPAR-γ (Cao et al., 1991; Wu et al., 1996) . Reinforcing this positive role of GCs in adipogenesis is the observation that both human and murine obesities are associated with hypercortisolism (Livingstone et al., 2000; Rask et al., 2001) . Insulin is also a crucial factor promoting adipogenesis and fat-specific disruption of the insulin receptor gene induces decreased adiposity in fat-specific insulin receptor knock-out (FIRKO) mice (Blüher et al., 2002) . Additionally, the prostaglandin PG 12, which is a major metabolite for arachidonate in adipose tissue, also favors adipocyte differentiation by inducing C/EBP-b and -d (Aubert et al., 2000) . Interestingly, adipocyte-secreted factors such as adiponectin, can also present pro-adipogenic properties, as recently reported (Fu et al., 2005) .
On the opposite, several environmental factors have been described that repress adipogenesis. Growth hormone (GH) stimulates lipolysis, consequently leading to decreased adiposity in vivo, and inhibits pre-adipocyte differentiation in vitro (Wabitsch et al., 1995) . Unlike PG 12 and adiponectin, two adiposesecreted factors: prostaglandin F2-a and resistin inhibit adipose conversion (Serrero et al., 1992; Kim et al., 2001) . Interestingly, despite the fact that elevated levels of circulating cytokines such as TNF-α and IL-6 are associated with increased fat mass and obesity (Dandona et al., 1998; Bastard et al., 2000) , those factors have been convincingly reported as being potent inhibitors of adipocyte differentiation (Gimble et al., 1994) , notably through suppression of PPAR-γ activity (Suzawa et al., 2003) . In line with these observations are the phenotypes of either IL-6 or TNF-α knockout mice, both fatter than controls (Wallenius et al., 2002; Xu et al., 2002) .
Considering now the role of nutrients as environmental factors controlling adipogenesis, it has been shown that diet-derived fatty acids can either promote or block adipogenesis, depending on their chain length and their degree of desaturation, but also according to the localisation of the adipose tissues (recently reviewed by Al-Hasani and Joost, 2005; Madsen et al., 2005) . To exemplify this, it is known that polyunsaturated fatty acids of the ω-6 series are more adipogenic both in vitro and in vivo, as compared with their ω-3 counterparts (Massiera et al., 2003) , and ω-3-enriched diet was even shown to be protective against obesity by favouring oxidation at the expense of storage (Raclot and Oudart, 1999) . Besides acting on adipogenesis via their metabolites such as arachidonic acid or prostaglandins, dietderived fatty acids are also able to directly bind to nuclear receptors like PPAR-γ, and thus have a direct effect on gene expression, adding a supplementary level of complexicity in the control of adiposity by fatty acids.
Beside fat, and among many other nutrients originating from diet that controlled adiposity, retinoic acid (RA), the carboxylic acid form of vitamin A, has emerged as a factor strongly influencing adipocyte differentiation (reviewed by Bonet et al., 2003) either by promoting (low doses) or inhibiting (high doses) in vitro adipogenesis. In vivo, diets, which are poor in RA, favoured adipose tissue formation, whereas acute RA treatment led to a strong decrease of body fat content (Ribot et al., 2001) . Again, these changes of adiposity in response to vitamin A were associated with alterations in PPAR-γ expression.
Obviously, lipogenesis, the development and function of adipose tissue, is responsive to dietary changes and it is the diet itself, i.e. carbohydrates, fatty acids and their metabolites, that induces the appropriate cellular programming, via the nutrient sensors, to make sure that the nutrients are correctly processed and stored.
I.3. Adipose tissue and calorie restriction.
Intentional weight loss by the mean of calorie restriction (CR) is known to improve most of the medical complications associated with obesity (Case et al., 2002) . Indeed, dietary interventions such as fasting or food restriction based on low-or very lowcaloric diets, constitute efficient therapeutic approaches to promote fat mass loss in obese patients. Nevertheless, although the beneficial of CR has been shown for many years and appears to come from changes in adipocytes and non-adipose cells from adipose tissue, its precise molecular mechanism remain largely unknown.
In case of prolonged fasting or heavy calorie restriction, some adipocytes shrink and adopt an elongate-or star-shaped phenotype, due to delipidation process (Blanchette-Mackie and Scow, 1981) . Recently, numerous studies have exploited the microarray approach (Leung and Cavalieri, 2003) to monitor changes in adipose tissue gene expression during calorie restriction.
In mice, compared with non-fasted controls, either 1 day-fasting or short CR (i.e. 23 days) has a slight effect on gene expression, contrasting with long CR (i.e. 9 months) which notably upregulates the expression of SREBP-1c (Higami and Pugh, 2004) . In addition, the effects of CR on fat mass loss have been studied in the genetic model of obesity resulting from leptin-deficiency (ob/ob mice, (Zhang et al., 1994) ) and compared with the ones induced by leptin administration (Halaas et al., 1995) . This study identified 8 groups of genes whose expression was different between leptin treatment and CR, suggesting that the energy restriction by itself may regulate adipose tissue gene expression independently of the fat mass loss (Soukas et al., 2000) .
Therefore, during adaptation to CR, fat is mobilized from WAT and adipocytes remain with minimal fat stores. It was recently proposed that sirtuins, acting through down-regulation of PPAR-γ, play a dominant role in these changes in WAT in response to CR, thus representing a molecular link connecting caloric restriction to reduced fat accretion (Guarente, 2005) .
Considering the resulting effects of calorie restriction in humans, it was recently reported that CR affects genes involved in metabolism and improves the inflammatory profiles (Viguerie et al., 2005) , therefore unravelling new aspects of adipose tissue biology such as the relationship between obesity and inflammation (Greenberg and Obin, 2006) . Further experiments are required to investigate the nature of the regulation of inflammatory markers during nutritional challenge and to determine if the modifications observed during calorie restriction result from phenotypical changes of resident macrophages and/or to a new monocyte/ macrophage infiltration in the adipose tissue.
I.4. Adipose tissue and obesity : the diet-induced obesity (DIO) model.
As previously stated, excess of adipose tissue mass i.e. obesity, arises from increased size of individual adipose cells due to lipid accumulation and/or from increased number of adipocytes arising from differentiation of adipose precursor cells to mature adipocytes under the appropriate nutritional and hormonal cues.
A large number of genetically-manipulated animal models, mostly mice, have been created for the study of adipose tissue biology. These models have been extensively and frequently reviewed (Blüher, 2005) . Nevertheless, despite having permitted to add key pieces to the complex puzzle of adipose tissue physiology, transgenic animal models have limitations and may not always necessarily match the human disease. In this regard, the dietinduced obesity (DIO) model may better reproduce human obesity than the genetic models. Recently, Moraes et al. (2003) reported, using oligonucleotide micro-array analysis, that approximately 500 genes were differentially expressed in adipose tissue of DIO-C57BL/6J mice. Interestingly, genes coding markers for adipocyte differentiation are down-regulated whereas there is no variation in the expression of the main adipogenic transcription factors, contrasting with the results obtained with adipose tissue from leptin-deficient obese ob/ob mice (Nadler et al., 2000) . This latter observation shows that the gene expression profile in adipose tissue of genetic models of obesity, such as the ob/ob mice, does not reflect the profile obtained with obesity induced by overfeeding, reinforcing the interest of these rodent models of diet-induced obesity.
In human obesity, recent studies have been conducted on obese adipose tissue using micro-array technology. From those reports, a tendency of down-regulation of genes involved in lipolysis has been described in adipose tissue harvested from obese individuals (Gomez-Ambrosi et al., 2004) . Complementary, both the expression of pro-adipogenic transcription factors and adipocytespecific markers are reduced in the adipose tissue of non-diabetic, insulin-resistant patients, indicating that insulin-resistance may be associated with impaired adipogenesis (Yang et al., 2004) . Finally, this technological approach was recently applied to analyse the effect of leptin treatment of obese individuals on the gene expression pattern in WAT (Taleb et al., 2006) . Surprisingly, it revealed that leptin treatment mainly impacted on the expression of genes related to inflammation and immunity.
II. Central nervous system, Genes and Nutrition.
Daily energy intake is variable both among and within individuals, depending on emotional, social or time variables, and is not necessarily correlated with daily energy expenditure (Edholm, 1997) . Reducing a behaviour as complex as feeding to a series of molecular interactions may be simplistic, but the recent discoveries over the past few years using genetically-modified murine models enlighten the role of molecules that modulate food intake and participate to energy homeostasis.
II.1. Adiposity signals acting on neurons: an emerging concept for the modulation of food intake?
Growing evidences support the existence of a bidirectional communication between adipocytes and brain. It was first related by Kennedy (1953) who proposed that signals generated in proportion to body fat stores, exert an inhibitory effect in the brain to reduce the food intake.
Besides the pancreatic hormone, insulin, one of the first peripheral signals entering into the brain from the circulation (Baura et al., 1993 ) to lower energy intake (Woods et al., 1979) , other molecules from the gastro-intestinal tract and from adipocytes are implicated in the central control of body weight. Two hormones from the gastro-intestinal tract: ghrelin and cholecystokinin (CCK), are transmitted to the brain via vagal afferent, eliciting respectively starvation and satiety signals (Date et al., 2005) . Additionally the adipose tissue secretes a cytokine-like molecule encoded by the ob gene, the hormone leptin (Zhang et al., 1994) that shares common features with insulin in the central regulation of food intake. Indeed, both hormones are secreted proportionally to body fat content and target the hypothalamus (Figure 1) . By acting on hypothalamic neurones, insulin and leptin repress the expression of genes involved in anabolic neural circuits that stimulate eating and activate catabolic genes that inhibit food intake and increase energy expenditure (Loktionov, 2003) . FIGURE 1. Schematic drawing adapted from Leibowitz FIGURE 1. Schematic drawing adapted from Leibowitz FIGURE 1. Schematic drawing adapted from Leibowitz FIGURE 1. Schematic drawing adapted from Leibowitz FIGURE 1. Schematic drawing adapted from Leibowitz and and and and and W W W W Wor or or or ortley (2004, tley (2004, tley (2004, tley (2004, tley (2004 25, illustrating the neuronal organisation involved in the regulation of the neuronal organisation involved in the regulation of the neuronal organisation involved in the regulation of the neuronal organisation involved in the regulation of the neuronal organisation involved in the regulation of food intake and energy expenditure. food intake and energy expenditure. food intake and energy expenditure. food intake and energy expenditure. food intake and energy expenditure.
II.1.a : Where does the "food intake" message reach the brain?
The need to eat is under complex regulation involving various body compartments such as gastro-intestinal tract, adipose tissue and brain. In the brain, the hypothalamus states as the main central structure that regulates food homeostasis. Two major hypothalamic nuclei "centres" were initially presumed to mediate hunger and satiety : the lateral and the ventromedial hypothalamus. Indeed, lesion of lateral hypothalamus provokes hypophagia (Anand and Brobeck, 1951; Mitchel and Keesey, 1977) whereas hyperphagia is induced by ventromedial hypothalamic lesion (Hetherington and Ranson, 1940; Keesey et al., 1979) . Current literature in the field sustains the existence of an even more complex and distributed network, with metabolic signals arising from periphery being processed by sensor neurones organised as anatomically discrete clusters within hypothalamus, amygdala, area postrema and nucleus tractus solitarius (NTS) or by groups of medullary serotonin and catecholamine neurones (Levin, 2001; Levin, 2002) . All these neurones display altered membrane potential, firing rate and transcriptional activity when activated by metabolic signals like glucose, fatty acid, lactate, ketone bodies, insulin and leptin (Levin, 2001; Levin, 2002) .
Recent molecular, physiological and anatomical studies have provided new insight on the role of the lateral hypothalamic area (LHA) and the mediobasal hypothalamus in the regulation of food intake and body weight. The LHA contains neurons that send fibres throughout the neuraxis including monosynaptic projections to the cerebral cortex (Saper, 1985) . Such innervation might play a key role in the integration of the complex physiology underlying the feeding behaviour and the initiation of feeding. Recently, Petrovich et al. (2005) have identified forebrain projection neurones to the LHA that are selectively activated by a learned cue that stimulates eating. In this behavioural situation, amygdala and prefrontal cortex neurones express two immediate-early genes having different temporal expression patterns (Arc, expressed 2-10 min after neuronal activation and Homer1a, which peaks at 25-35 min). These data underline the existence of a direct functional pathway from amygdala and prefrontal cortex to LHA that could play a pivotal role in regulating the impulse to eat in response to appetitive signals with high incentive value.
Moreover, LHA as well as the ventromedial nucleus are targets of inputs coming from arcuate nucleus. Indeed, specific hypothalamic lesions induced by administration of monosodium glutamate (Olney, 1969) or gold thioglucose (Debons et al., 1977) , respectively damaging the arcuate nucleus and the ventromedial nucleus, cause obesity and hyperphagia. The arcuate nucleus lies in the ventral hypothalamus, along the third ventricle. It resides above the median eminence and shares connections with the subfornical organ, i.e. regions where the blood-brain barrier is compromised (Lind, 1987) . Thus, the arcuate nucleus constitutes a key site for integration of peripheral signals in relation with the regulation of feeding, as its neurons express leptin receptors . Indeed, viral transfection of leptin receptor in arcuate neurons is sufficient to cause reduction of food intake in leptinreceptor deficient mice (Morton et al., 2003) . Moreover, Zucker fatty (fa/fa) rats, deficient in functional leptin receptors, develop hyperphagia on postnatal day 12 (Kowalski et al., 1998; Kowalski et al., 1999) . Taking in consideration these data, Bouret et al. (2004a Bouret et al. ( , 2004b recently demonstrate the trophic role of leptin in the formation of projection pathways from the arcuate nucleus to dorsomedial hypothalamic nucleus, hypothalamic paraventricular nucleus (PVN) and LHA in neonatal mice from postnatal days 5 to 16. In particular, exogenous leptin treatment of leptin-deficient ob/ob neonate mice rescues the development of arcuate nucleus projections (Bouret et al., 2004a) . Thus, the hypothalamic projections of arcuate nucleus point out its participation to monitor the leptin-signalling throughout the brain.
II.1.b : How do brain genes "integrate the food signals"?
Signals coming from the periphery are integrated by metabolic sensor neurons and their summated activity is transmitted via neural and hormonal outputs to the periphery. Energy homeostasis is centrally controlled by transmitters such as gamma-aminobutyric acid (GABA), glutamate, catecholamine or serotonin and neuropeptides both found in various parts of the brain, but also in peripheral organs such as the gut (Berthoud, 2002) . Among the variety of hypothalamic factors that mediate energy homeostasis, some exert an orexigenic action whereas others are anorexigenic (T T T T 
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The central mechanisms regulating feeding usually require a variety of neurotransmitters that exert more a modulatory effect than an executive one. These neuromediators are clustered in various parts of the brain and their widespread innervations target different cerebral structures involved directly or not in food intake. As an example, the meso-limbic dopaminergic system contributes to give a hedonic/rewarding value of the food. This component is under the regulation of GABAergic and/or glutamatergic neurones. Furthermore, the brain serotonin (5-HT) systems also contribute to regulate eating behaviour and energy homeostasis as mice exhibiting a mutated 5-HT 2C receptor gene show hyperphagia independent from leptin plasma levels (Tecott et al., 1995; Nonogaki et al., 1998) . Additionally, the 5-HT 1B receptors mediate the anorexic actions of the 5-HT (Lee et al., 2004) . In 24h-fasted mice, the hypothalamic 5-HT 1B receptor and 5-HT 2C receptor mRNA levels are augmented in parallel with the increase of plasma active ghrelin levels (Nonogaki et al., 2006) .
As previously evoked, LHA and arcuate nucleus constitute key hypothalamic structures to integrate food signals. The LHA is composed by neuronal populations containing melaninconcentrating hormone (MCH), that is also present in neurones of the hypothalamic perifornical area and zona incerta (Bittencourt et al., 1992) , and orexin (ORX, ) also called hypocretins (HO, (De Lecea et al., 1998) ). These latter peptides, when intracerebroventricularly injected, increase food intake; their mRNA are also elevated during fasting Qu et al., 1996) . The MCH and ORX neurones receive inputs from the neuropeptide Y-(NPY), Agouti-related protein-(AgRP) and a melanocortin stimulating hormone-(α-MSH) immunoreactive fibres coming from the arcuate nucleus (Elias et al., 1998) . Such innervation may link peripheral metabolic signals to cerebral cortical areas in order to generate the feeding sensation.
Regarding the arcuate nucleus, it contains populations of neurons that play an important role in distributing leptin signals in the brain. A first neuronal population contains the orexigenic neuropeptide NPY. Most of these neurons project to the PVN (Bai et al., 1985) . In fact, intra-PVN injection of NPY increases food intake, more specifically carbohydrate intake (Stanley et al., 1985) . Arcuate NPY neurons also send innervation to amygdala, an area also involved in feeding behaviour since lesion of amygdala produces obesity and increases preference for high carbohydrate diet (King et al., 1998; King et al., 2003) . When administrated into the amygdala, NPY selectively reduces high fat food intake and preference, without altering total caloric intake (Primeaux et al., 2006) . As an antisense inhibition of NPY-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and increases feeding, amygdalar effects of NPY may be related to the overall emotional state: a NPY-induced reduction in anxiety might be responsible for the NPY-induced reduction in fat intake. A high percentage of NPY neurons co-express AgRP (Hahn et al., 1998) . The agouti mutation (A g /a) includes an over-eating/obesity syndrome distinct from that seen in the ob/ob mice, as it is due to antagonism of type 3 and 4 of the melanocortin receptors (Fan et al., 1997) . During fasting, the AgRP mRNA is increased, suggesting its orexigenic properties. Besides NPY/AgRP neurons, arcuate nucleus also contains another subpopulation of neurons containing melanocortin peptides (〈−MSH), the proopiomelanocortin (POMC) gene product, and characterized by their anorexigenic effects. In the ob/ob mice or in fasted rodents, the markedly reduced POMC mRNA expression can be prevented by exogenous leptin administration Thornton et al., 1997) . POMC neurons innervate the PVN, the melanocortin concentrating hormone (MCH) and ORX/HO neurons of the LHA, as well as sympathetic preganglionic neurons (Saper et al., 2002) . Finally, another peptide is expressed in the arcuate nucleus: CART (cocaine and amphetamine related transcript) (Couceyro et al., 1997; Koylu et al., 1997) . The CARTneurons modulate feeding behaviour since central injection of a CART-specific immunserum, increases food intake (Koylu et al., 1997) . Moreover, as previously stated for POMC neurons Thornton et al., 1997) , administration of leptin provokes an elevation of CART mRNA (Kristensen et al., 1998) . Virtually all arcuate CART neurons coexpress POMC (Elmquist et al., 1999) . The sites of action of these leptin-regulated CART neurons that may be involved in the inhibition of food intake are currently unknown even if some evidences show the presence of terminals on central autonomic sites, like the sympathetic preganglionic spinal cord neurons (Koylu et al., 1997) . Altogether, these hypothalamic neurons constitute a complex network ensuring connections to acutely regulate peripheral signals and to spread them within the brain.
II.1.c : Hypothalamic integration of the leptin signal.
As underlined before, leptin action illuminates the hypothalamic satiety network. Its existence was hypothesized by Coleman et al. (1969; 1973) in studying two mutant mouse strains, namely the ob/ob and db/db mice which have a phenotype of massive overeating, obesity and delay of sexual maturation. Further, this peptide hormone was cloned and demonstrated to be mainly synthesized by adipose cells (Zhang et al., 1994) , in proportion to the adipose-cell mass (Maffei et al., 1995) although a recent study reports a partial leptindeficiency in patients having an increased body fat mass (Farooqi et al., 2001) . Leptin release occurs in response to a food intake signal to act both peripherally and in the brain (Auwerx and Staels, 1998) . Leptin enters the brain via transporters across the blood-brain barrier and reaches the hypothalamic targets described above. This transport is decreased in diet-induced obesity (DIO) and aging, and might contribute to leptin resistance, excess adiposity and glucose intolerance (Banks et al., 1999) . It was shown that systemic injection of leptin induces expression of the immediate-early gene c-fos in arcuate nucleus, ventromedial nucleus, dorsomedial nucleus, and ventral parvocellular part of the PVN (Elmquist et al., 1997) .
Leptin receptors are members of the cytokine-receptor superfamily (Tartaglia et al., 1995; Tartaglia, 1997) . Especially, leptin binds to cytokine type I receptors, which signal through the JAK (janus kinases) -STAT (signal transducer and activator of transcription) pathway (for more details see (Tartaglia et al., 1995; Schwartz et al., 2000) ).
Interestingly, in the central nervous system, leptin receptors are expressed in the hypothalamus (arcuate, dorsomedial, ventromedial nuclei, PVN and LHA), but also in several brainstem areas, like nucleus tractus solitarius (NTS) (Ahima, 2005) . Leptin receptors are present on arcuate NPY/AgrP neurons , mediating the effects of leptin on food intake. An increase of leptin or high-fat diet suppresses these peptides, particularly by an activation of inhibitory components of the JAK-STAT pathway, the suppressor of cytokine signalling 3 (SOCS-3) (Bjorbaeck et al., 1998) . SOCS proteins are rapidly induced by activation of the type I cytokine family receptors, among which leptin and IL-6 receptors (Tartaglia et al., 1995) . Moreover, leptin increases levels of the arcuate anorectic peptides, αMSH and CART, as leptin receptor mRNA is coexpressed in a very high percentage of arcuate POMC neurons Ahima, 2005) .
Recently, leptin has been demonstrated to act also directly on ventromedial hypothalamus where it depolarizes and increases the firing rate of steroidogenic factor-1-positive neurons (Dhillon et al., 2006) . The steroidogenic factor-1, is a transcription factor expressed in the ventromedial hypothalamus, essential for the normal development of this hypothalamic structure. Indeed, steroidogenic factor-1 gene KO mice have abnormal ventromedial hypothalamus development and are obese (Majdic et al., 2002) . Furthermore, transgenic mice that lack leptin receptors on these steroidogenic factor-1-positive neurons increase food consumption and fat stores (Dhillon et al., 2006) .
In human, impressive is the finding that treatment with leptin reverses the obese phenotype in leptin-deficient humans (Farooqi et al., 2002) . In contrast, the majority of obese patients have high circulating leptin levels (Caro et al., 1996) , strongly suggesting the existence of leptin resistance in hyperleptinemic obese subjects. The cause of leptin resistance in most forms of human and rodent obesity is not yet fully defined. Nevertheless, as we stated above, in DIO mice, a classical mouse model of leptin resistance and obesity, it was shown that the level of suppressor of cytokine signaling 3 (SOCS-3), an inhibitor of leptin signaling, is increased in the arcuate nucleus of DIO mice, bringing a clue to the molecular mechanisms underlying the development of central leptin resistance (Münzberg et al., 2004) . The central action of leptin described above, adds to the one of other peripheral factors, notably those originating from the intestinal tract. (Figure 2 ).
II.2.a : Signals from gastro-intestinal mechanoreceptors.
Gastro-intestinal mechanoreceptors sensitive to volume detection intervene directly via the vagus nerve in the short-term satiety. Precisely, the two putative mechanoreceptors that the vagus nerve supplies to gastrointestinal smooth muscle are intraganglionic laminar endings (IGLEs) and intramuscular arrays. A knock-out mice model, deficient in the neurotrophin-4 (NT-4) gene, exhibits selective losses of these endings. As a consequence, these mutants show a substantial organ-specific reduction of IGLEs, mostly in the small intestine. These morphologic changes are linked with a differential meal pattern characterized by increased meal durations with solid food and increased meal sizes with liquid food without any modifications in the daily total food intake and body weight. Thus, this work ascertains that NT-4 may participate in shortterm satiety, probably by conveying feedback about intestinal distension or transit to the brain (Fox et al., 2001 ).
II.2.b : Signals from nutrients.
Changes in the circulating levels of nutrients such as ketone, fatty acids and/or glucose contribute to modulate food intake in animals (Smith and Epstein, 1969 , recently reviewed in Prodi and Obici, 2006) as well as hunger sensations and food intake in humans (Thompson and Campbell, 1977) .
Ketones, products of the hepatic fatty acid oxidation, are released into the central and peripheral circulation and provide a feedback signal for control of feeding since inhibitors of fatty acid oxidation generate a hyperphagic state (for review see Scharrer, 1999) . In humans, Kamphuis et al. demonstrate that diacylgycerol treatment increases fat oxidation and appetite (Kamphuis et al., 2003) . The feelings of hunger, appetite, estimated prospective food intake, and desire to eat augment significantly after two days with diacylgycerol treatment without altering energy expenditure. The exact location of metabolic neuronal sensors responding to fatty acid oxidation and controlling food intake still remains largely unknown. However, the feeding responses of rats to fat depends on intact abdominal vagal afferents that project to brainstem structures, the NTS and the adjacent circumventricular area postrema, important relay for visceral and gustatory afferents. Recently, Laugerette et al. (2006) brought a molecular explanation for the fatty-food preference, that is localized in the oral cavity. Indeed, increased palatability of foods could partly override the feeling of satiety and result in hyperphagia. Among foods, dietary fats are certainly the more palatable and, in addition to their high caloric nature, directly influence food intake (Warwick et al., 2003) . The authors reported the participation of CD36 (a fatty acid transporter and scavenger receptor for oxidized Low Density Lipoprotein), as a taste receptor for fatty acids in lingual papillae, leading to spontaneous fat preference and digestive secretions. In this study, CD36-null mice showed a lost of palatability of the fat-enriched solutions that was noticed in the wild-type (WT) control animals. Moreover, this effect appeared to be restricted to lipid detection, since the preference for sucrose and the aversion for quinine remained unchanged in CD36-null and WT mice. Nonetheless, CD36 expression seemed to be up-regulated either in in vitro culture-derived human monocytes/macrophages, by glucose (Griffin et al., 2001; Hayek et al., 2005) or in different organs and tissues from diabetic animals (small intestine, heart and adipose tissue) (Ibrahimi and Abumrad, 2002; Chen et al., 2006) , possibly questioning on the consequence of hyperglycemia on the expression of CD36 in the oral cavity, and thus on the preference for fat.
The general postulate that food intake is affected by plasma glucose levels through the mediation of specialized glucoreceptors which are sensitive to the fluctuations of blood glucose is an old one, referred to as the "Glucostatic hypothesis" (Mayer et al., 1953) . It is known that decreased glucose plasma levels stimulate appetite by influencing the firing rate of specialized neuronal populations in the ventromedial and lateral hypothalamus as their responses increase following application of glucose (Oomura et al., 1969 , Levin, 2002 .
Finally, several lines of evidence support the notion that lipid metabolism in neurons plays a critical role in mediating hypothalamic responses to fuel availability. Two metabolites, malonyl-conenzyme fatty acyl-CoA (malonyl-CoA) and longchain fatty acyl-CoAs have emerged as probable signaling molecules in the hypothalamus. The role for malonyl-CoA in regulating food intake was first recognized through the discovery that intraperitoneal or intracerebral administration of inhibitors of fatty acid synthase (FAS), such as cerulenin and C75, causes an accumulation of malonyl-CoA in the hypothalamus and has a profound anorexigenic effect (Loftus et al., 2000) . Likewise, intracerebral administration of long-chain fatty acids, e.g. oleic acid, reduces food intake, demonstrating that certain fatty acids do have an inhibitory central effect on feeding control (Morgan et al., 2004) . Thus, it appears that under physiological conditions hypothalamic malonyl-CoA is an important determinant of feeding behavior (recently reviewed in Prodi and Obici, 2006) . FIGURE 2. Schematic illustration adapted from Havel FIGURE 2. Schematic illustration adapted from Havel FIGURE 2. Schematic illustration adapted from Havel FIGURE 2. Schematic illustration adapted from Havel FIGURE 2. Schematic illustration adapted from Havel (2001, (2001, (2001, (2001, (2001 
II.2.c : Signals from gastro-intestinal hormones.
The food intake is strictly controlled by various gastro-intestinal hormones. Each, except the stomach-derived product ghrelin, inhibits food intake. The cholecystokinin (CCK), released from endocrine cells in the mucosal layer of the proximal small intestine following ingestion of dietary fat and small proteins, transmits food signals to hindbrain via vagal afferent inputs, by activating CCK A receptors located in pylorus and liver. In rats, ingestion of a satiating meal or exogenous injection of CCK causes the immediate early-gene c-fos expression in the medial NTS (Monnikes et al., 1997; Rinaman et al., 1998; Zittel et al., 1999) . Since CCK does not readily cross the blood brain barrier, it acts indirectly on CCK A receptors located on vagal afferents which terminate in the NTS (Moran et al., 1997) or area postrema (Carlberg et al., 1992) , circumventricular organ strongly activated by CCK (Rinaman et al., 1993) and establishing monosynaptic connections with the NTS. A large majority of the CCK-activated NTS neurons are catecholaminergic (Myers and Rinaman, 2002) and send projections to the central amygdala (Myers and Rinaman, 2002) , a telencephalic brain area that participates in the regulation of visceral functions, like for example gastrointestinal activities (Jia et al., 1997) in relation with emotional reactivity by its connectivity with hypothalamus (Davis, 2000) .
Besides CCK, ghrelin is a hormone synthesized in the stomach which plasma levels increase during food deprivation in animals (Kojima et al., 1999) . Originally identified to exert a stimulatory effect on growth hormone secretion via a growth hormone secretagogue receptor (Bowers, 2001; Kojima et al., 2001) , ghrelin stimulates food intake in satiated rodents (Tschop et al., 2000) . Additionally, ghrelin may be involved in meal initiation as a noticeable preprandial increase in its plasma levels has been reported in humans (Cummings et al., 2001 ). The orexigenic effect of ghrelin appears to be mediated via the NPY/AgRP pathway. Indeed, ghrelin administration induces immediate-early gene expression in NPY neurons (Dickson and Luckman, 1997) and provokes increases in the NPY and AgRP mRNA expression in the hypothalamic arcuate nucleus (Kamegai et al., 2000; Asakawa et al., 2001; Nakazato et al., 2001; Shintani et al., 2001) of fed rats as these neurons express ghrelin receptors (Willesen et al., 1999) . In humans, the gastric bypass operation of morbidly obese patients results in a marked body weight loss associated with a great reduced ghrelin levels (Cummings et al., 2002) . These observations reflect a key role of the ghrelin in the motivation for feeding although the central circuits through which ghrelin exerts its effects remain largely unknown.
Interestingly, one of the "adiposity signal", namely the adipocyte-derived hormone leptin, was recently reported to be secreted by cells of the gastric mucosa and therefore participate to the regulation of meals, leading to viewing gastric leptin as a neuroendocrine key for satiety (Cammisotto et al., 2005) . Indeed, leptin is found in the stomach where it is mainly secreted by the lumen (Bado et al., 1998) , and leptin receptors have been identified on the intestinal brush borders (Sobhani et al., 2000) . Leptin secretion in the stomach is regulated by feeding, with its secretion being rapidly increased following a meal (Attoub et al., 1999) , and intestinal hormones CCK (Bado et al., 1998) . Additionally, there appears to be an interaction between CCK and leptin, since leptin can induce CCK release (Guilmeau et al., 2003) and vice versa (Bado et al., 1998) , leading to a synergistic effect on short-term inhibition of food-intake (Barrachina et al., 1997) and long-term reduction of body weight (Matson and Ritter, 1999) .
II.2.d : Signals from peripheral endocrine factors.
Other endocrine factors, like glucocorticoids, thyroid hormones and cytokines, intervene in the brain to regulate food intake. Besides their catabolic effects in the periphery, glucocorticoids exert anabolic effects at the central level, increasing food intake (Tempel et al., 1992) . These adrenal hormones exert their orexigenic effects through the hypothalamic neuropeptide systems involved in the inhibition of food intake following release of insulin and/or leptin La Fleur, 2006) . As an example, using a model of transgenic mice in which the POMC transgene is introduced in mice with a POMC null mutation, in order to re-establish the peripheral melanocortin and corticosterone secretion, Smart et al. (2006) demonstrate that restoration of pituitary POMC expression to create a de facto neuronal POMC deficiency, exacerbated the development of obesity, largely via glucocorticoid modulation of appetite, metabolism, and energy partitioning.
Other steroid hormones such as the thyroid hormones, influence the feeding behavior even if the mechanism of action is again not well understood. In the Graves' autoimmune disease (Graves' thyrotoxicosis), the thyroid gland produce large amount of thyroid hormone, causing lost of weight, despite increased appetite and food intake, therefore suggesting a disturbed balance between energy intake and expenditure. Rojdmark et al. (2005) recently show that hormonal factors, known to affect hunger/satiety, change significantly over time as pharmacological treatment turns hyperthyroidism into euthyroidism. Indeed, free T3, T4, and glucose levels drastically decline from hyperthyroidism situation to the restored euthyroidism whereas cortisol, insulin, growth hormone (GH), and leptin levels are similar. Both ghrelin secretion and IGF-1 bioavailability are low in patients with untreated thyrotoxicosis, but increase markedly as pharmacotherapy makes them euthyroid. These data support the works of Lin et al. (1983) where central administration of thyrotropin-releasing hormone suppress food intake by exerting a hypothalamic feedback inhibition.
Finally, a number of pro-inflammatory cytokines, like interleukin-6 (IL-6), inhibits food intake (for review see (Plata-Salaman, 1995) ). IL-6, mainly produced by macrophages, T lymphocytes and adipocytes, exerts its inhibitory feedback on the body fat mass via hypothalamic receptors, and IL-6-deficient mice develop mature onset obesity and decreased glucose tolerance (Wallenius et al., 2002) . However, a direct role of this cytokine in food intake regulation under physiological conditions is still not completely established. (Schaffler et al., 2005) . Most of these hormones have a short half-live, are released rapidly and followed a circadian rhythm (Cohen et al., 1986) . Thus, they may regulate the adipocyte function very quickly by modulating adipokine gene expression. The fast-acting adipocyte response to pituitary gland hormones and hypothalamic peptides would potentially give a physiological substrate for a rapid regulation of insulin/ leptin sensitivity, lipid synthesis or breakdown, glyconeogenesis, satiety or appetite. Alterations in the gene expression of these receptors might be at the origin of some forms of obesity. As examples, the obesity generally observed in hypothyreosis, which is accompanied by drastic elevation of TSH plasma levels, might be the result on a direct action of TSH on adipocytes to regulate energy metabolism. Additionally, in the Cushing's disease, the excess of fat is commonly explained by the increased cortisol secretion, but could also be due to the related release of ACTH acting on adipocytes.
Taken as a whole, these data reflect the reciprocal dialog between brain, adipocyte and gastro-intestinal tract. A better understanding of how the genes involved in food consumption are regulated remains an essential question. It should ultimately help individuals to better adapt their food intake and thus solve, at least in part, health problems linked to obesity or anorexia and their metabolic/ psychological consequences.
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In addition to the central nervous system, the "Enteric Nervous System" is located in sheaths of tissue lining the oesophagus, stomach, small intestine and colon, and holds about 100-million nerve cells more than in spinal cord. Less complex and smaller than the cranial brain, the gut's brain contains between 70 to 85 per cent of the body's immune cells, is an independent dataprocessing centre handling a complicated circuitry of neurons, neuromodulators and neurotransmitters. As evoked above, the enteric nervous system is in constant interaction with both the adipose tissue and the central nervous system.
In addition to this, the gut also contains an immense number of microorganisms, collectively defined as the microbiota. We will now focused on the impact of intestinal microbiota in normal bowel function and in the maintenance of host's health through metabolic and immunological activities. Human and other mammals are colonized by a vast, complex, and dynamic bacterial community. In human, the number of microbes associated with mucosal surfaces exceeds by 10 times the total number of cells. Constituted of more than 1000 species, the microbial collective genomes are estimated to contain 100 times more genes than the human genome (Savage, 1977) . Indeed, recent work using a large-scale comparative analysis of 16S rDNA sequences of adherent mucosal and fecal microflora, has shown 13,355 prokaryotic ribosomal RNA gene sequences (Eckburg et al., 2005) . A large fraction of the dominant gut microbes remains unculturable, 80% of the phylotypes deriving from microorganisms have no culturable representative. The proportion of such un-recognized species increases from birth to the old age. Metagenomics approaches have been initiated to address the collective genomes of the intestinal microbiota, know as the microbiome (Egert, 2006; Zoetendal, 2006) . Complementary to metagenomics, meta-transcriptomics, meta-proteomics and meta-metabolomics approaches have been initiated and are expected to provide further insights into the in situ activity of the intestinal flora.
In the intestine, microflora is in permanent contact and reciprocal interaction with host cells and nutrients, therefore composing an extremely complex and highly regulated ecosystem. The intestinal microbiota plays an important role in normal gut function and maintenance of host's health. It established immediately after birth and is now considered to be essential in priming the immune system during ontogeny. Different factors contribute to the protective function of gut microflora such as : 1 1 1 1 1 maintaining a physical barrier against colonization or invasion by pathogens, 2 2 2 2 2 facilitating nutrient digestion and assimilation, and 3 3 3 3 3 providing immunological surveillance signals at the gut mucosa-lumen interface. Comparison of conventionally-raised rodents with germfree counterparts has revealed a series of anatomical, biochemical and physiological phenotypes collectively known as MicrofloraAssociated Characteristics (MACS) (Hooper et al., 2002) .
In addition, the presence of a microflora increases intestinal epithelial turnover. Commensal bacteria may directly influence the intestinal epithelium to limit immune activation. Recently Neish et al. (2000) demonstrated that avirulent Salmonella abrogates production of inflammatory cascade by inhibiting ubiquitination and degradation of IkB, thus blocking the transactivation of NFkB-mediated genes. More recently, Kelly et al. (2004) identified an interesting mechanism by which commensal flora may regulate host inflammatory responses and maintain immune homeostasis, by promoting nuclear export of NFkB subunit relA, through a PPAR-γ-dependent pathway. Similarly, Rakoff-Nahoum et al. (2004) demonstrated that recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis, explaining why disequilibrium in this signalling pathway can lead to the initiation of inflammatory bowel diseases.
Finally, it has been reported that microflora deconjugates and dehydroxylates bile acids Jones, 2004) , metabolizes bilirubin (Saxerholt and Midtvedt, 1986) , reduces cholesterol (Roller, 2004; Chiu, 2005) , and degrades mucus glycoproteins produced by the intestinal epithelium's goblet cell lineage (Hooper et al., 2002) .
III.1.b : Microflora composition is influenced by nutrition.
As evoked above, assembly of the gut microflora commences at birth and its composition will undergo dramatic changes during postnatal development. When space and nutrients are not limiting, commensals with high division rates predominate. As the population increases and nutrients are depleted, niches become occupied with more specialized species (Falk et al., 1998; Hooper et al., 1999) . The ability of other commensals to enter these occupied niches will depend on their ability to utilize the nutrients substrates more efficiently and/or to modify the nutrient reservoir to better suit their own metabolic capacities. Therefore, an equilibrium between microbial nutrient utilization and host nutrient production should be achieved, not to be deleterious to each other (Hooper et al., 1999) .
In addition to environmental factors such as nutrients, the adult bacterial community is also influenced by host genotype. Indeed, fecal 16S rRNA profiles of the flora of monozygotic twins are more similar than those of unrelated individuals or marital partners (Zoetendal et al., 2001) . Nevertheless, despite the variations in the composition of the microbiota between and within individuals, there is a functional stability insuring the basic set of biochemical reactions, such as degradation of carbohydrates, fermentation and synthesis of vitamins. Interestingly, conventionally-raised animals require less calorie intake to maintain their body weight than germ-free counterparts, suggesting the beneficial aid of the microbiota in extracting maximum nutritional value from the diet (Wostmann et al., 1983) . It shows that there is a continuous host-microbe-nutrient exchange leading to symbiosis, commensalism or pathogenicity.
Factor such as diet and antibiotic therapy are of undoubted importance in modulating the composition and metabolic activities of the colonic microflora. The greatest changes in species composition occur during the natural process of bacterial colonization in infancy.
Diet is a key factor regulating the sequence of colonization. In breast-fed infants, the intestinal flora is dominated by bifidobacteria, while formula-fed infants have a more diverse flora (Benno et al., 1984; Harmsen et al., 2000) . In breast-fed infants, the microflora produces high amounts of acetate and lactate restricting the growth of potential pathogens such as Escherichia coli and Clostridium perfringens (Wang and Gibson, 1993) . In comparison, in formula-fed infants, relatively high amounts of propionate and butyrate are produced. The favoured growth of bifidobacteria in breast-fed infants is likely due to the presence of neutral oligosaccharides with prebiotic effect, in woman milk (Engfer et al., 2000) . Alike human milk, the addition of prebiotics (i.e. non-digestible food ingredients) to infant regimen, stimulate the growth of beneficial endogenous bacteria. As an example, feeding infants with galacto-and fructo-oligosaccharides formula significantly increased the number of bifidobacteria Moro et al., 2002) .
Finally, a certain number of studies revealed age-related changes in the composition of the human gut microbiota (Mitsuoka et al., 1975) . A recent molecular cross-sectional study performed on intestinal microbiota composition from different European countries (Mueller et al., 2006) showed differences in microbiota composition, notably concerning the proportion of bifidobacteria, that may be explained by host specificities or diet-related differences. Additionally, higher proportions of enterobacteria were found in all elderly volunteers independently of the geographic location.
III.1.c : Metabolism and commensal flora: sugar and lipid metabolism, fat storage, angiogenesis.
As described in the first section of our review for the adipose tissue, the microbiota can be viewed as a true metabolic organ. The main studies that showed microbial contribution to nutrient metabolism has been done by the use of the commensal Bacteroides thetaiotaomicron (Hooper et al., 2002) . Using geneticallymodified bacteria, several genes have been identified that participate in carbohydrate metabolism, such as those encoding SusC-SusF outer membrane proteins, involved in the binding of starch to the bacterial surface allowing its digestion by α-amylases encoded by sus-A and sus-G genes (D'Elia and Salyers, 1996) . These genes are under the regulation of a transcriptional activator (sus-R) that senses maltose or larger oligosaccharides.
The capacity of B. thetaiotaomicron to degrade a variety of host-derived glycoconjugates, such as chondroitin sulphate, has also been linked to other genes, such as csuF encoding a potential receptor for these glycoconjugates, and chuR controlling the expression of the genes involved in the utilization of glycans (Cheng et al., 1992) . This is essential since host glycans are critical for B. thetaiotaomicron survival in the intestinal ecosystem.
Other host molecules, such as mucins and glycosphingolipids, can also be degraded by bacterial enzymes (Lowe et al., 1998) . Altogether, by serving as nutrient sources, these microbe-degraded host glycans establish a mutually beneficial host-bacterial interaction.
In parallel, this symbiotic relationship between host and bacteria also involved microbial fermentation processes. The predominant end-products of bacterial fermentation in the gut are short chain fatty acids, such as acetate, propionate and butyrate. Acetate is taken up primarily by peripheral tissues and can also be utilized by adipocytes for lipogenesis (Bergman, 1990) . The intestinal ecosystem also plays a crucial role in the metabolism of lignan, a dietary phytoestrogen coupound from plant origin, which could be involved in colon cancer, atherosclerosis and diabetes. Clavel et al. (2005) , recently showed that conversion of dietary lignans results from the catalytic activities of bacteria present in the intestinal tract.
The intestinal microflora also contributes to amino-acid synthesis. Indeed, high concentration of urea are found in the colons of germ-free rats, indicating the key role played by the bacteria in nitrogen recycling in the gut (Moreau et al., 1976) . Combining gnotobiotic mouse models with functional genomics, Hooper et al. recently further defined the impact of bacterial gut colonization on host's physiology. Indeed, using micro-arrays and laser capture microdissection, these authors followed the changes in gene expression in gut colonized with each components of the normal microbiota, in comparison to germ-free intestines (Hooper et al., 2001; Hooper et al., 2002; Stappenbeck et al., 2002a) . It showed modifications in the expression of genes involved in the processing and absorption of carbohydrates or in the breakdown and absorption of complex dietary lipids. Considering B.
thetaiotaomicron, that we previously mentioned, its proteome contains 172 glycosyl-hydrolases that are predicted to cleave most glycosidic linkages encountered in human diets .
Along the same lines Bäckhed et al. (2004) , recently reported that germ-free mice re-colonized with normal microbiota rapidly develop a 60% increase in body fat mass associated with insulinresistance, despite reduced food intake. As expected (Maffei et al., 1995) , these mice present increased leptin levels, proportional to the increase of body fat. These studies also revealed that microbiota promotes the absorption of monosaccharides from the gut lumen, resulting in the induction of de novo hepatic lipogenesis. Indeed, colonization with microbiota induces significant elevations in the expression of two key enzymes of the de novo fatty acid biosynthetic pathway, acetyl-CoA carboxylase (Acc1) and fatty acid synthetase (Fas), as well as gene expression of transcription factors involved in hepatocyte lipogenic responses to insulin and glucose. Moreover, the microbiota also promotes the storage of triglycerides in adipocytes through suppression of intestinal expression of a circulating lipoprotein lipase (LPL) inhibitor: the fasting-induced adipocyte factor (FIAF). Fiaf, also known as angiopoietin-like protein 4, is produced by brown and white fat, liver, and intestine. Quantitative RT-PCR analysis of intestinal Fiaf expression during the postnatal period disclosed that the gene is induced in germ-free mice during the suckling-weaning transition. During this period, the diet switches from lipid/lactoserich mother's milk to low fat/polysaccharide-rich chow, with coincident expansion of the microbiota and a shift from facultative to obligate anaerobes, such as Bacteroides. This repression is thus consistent with an accompanying augmentation of host lipid absorption. Interestingly, the Zebrafish homolog of mouse Fiaf is also suppressed by the microbiota when germ-free fish are colonized, indicating that this phenomenon has been highly conserved over the course of vertebrate evolution (Rawls et al., 2004) .
Therefore, microbial suppression of intestinal Fiaf promotes adiposity and Bäckhed et al. (2004) postulate that increasing Fiaf expression and/or activity may promote leanness, opening new therapeutic strategies for the treatment of adipose-tissue associated pathologies, among which obesity.
In addition to playing a role in adipogenesis and adipose tissue functionality, microbiota plays a key role in constructing the microvascular network by increasing expression of angiogenin-3 in the crypt epithelium, a secreted protein with angiogenic activity, within paneth cells (Hooper et al., 2001) . These findings enlarged the participation of microbiota in the whole physiology of an organism to an unexpected role in postnatal development (Stappenbeck et al., 2002b) .
To conclude, we will now exemplify selected findings describing the influence of environmental factors on the quality of the intestinal flora. Regarding this, any changes in microbial ecology prompted by western diets, and/or differences in microbial ecology, may impact on the health.
Molecular analysis of the bacterial microbiota based on the 16S rRNA genes have attracted attention as reliable methods to follow the microbial diversity and particularly how it could be affected in a particular environment (Ducan et al., 2003) . First, a recent study showed that short-course antibiotic challenges strongly and long-lastingly modulate bacterial microbiota explaining certain susceptibilities to antibiotic-associated diarrhea (De La Cochetiere et al., 2005) . Second, in case of chronic intestinal inflammatory diseases, such as Crohn disease (CD), it was reported that faecal microbiota of patients with CD contains a markedly reduced diversity of Firmicutes, compared with healthy donors (Manichanh et al., 2006) . This observation is of crucial importance since the indigenous microflora is considered to be the main factor triggering this inflammatory disease. Indeed, the reduced proportion of Firmicutes may lead to an increase of gram negative bacteria with pro-inflammatory activities. Moreover, some Firmicutes produce large amount of butyrate interfering with the NFkB activation cascade, consequently inhibiting inflammation. The tenet "Let food be thy medicine and medicine be thy food" espoused by Hippocrates nearly 2,500 years ago, has recently received renewed interest with the emerging concept of "functional foods". This term, first introduced in Japan in the mid-1980's, referred to processed foods containing ingredients that aid specific body functions in addition to being nutritious. The current definition of "Functional foods" is the following : "Foods or dietary components that may provide a health benefit beyond basic nutrition" (International Life Sciences Report, 1999) .
The interest in the ability of functional foods to impact on human health has rapidly grown recently, so has accumulated knowledge detailing their beneficial roles. In the last decade of the 20 th century, consumers began to view their diets from a radically different vantage point. Our diet is now considered as a first line of defences in the prevention of various chronic diseases of aging ranging from diabetes and obesity to cancer and cardiovascular diseases (Hasler, 2000) .
III.2.b : Functional food: Concept.
A large variety of foods provide health-benefits by altering one or more physiologic processes. The ability of specific foods to prevent and/or reduce the severity of symptoms and diseases come from a series of ancient reports. Currently, dozens of physiologically-active functional food components, from plants (i.e. phyto-chemicals) as well as animals (i.e. zoo-chemicals) are under investigation for their potential role in disease prevention and health promotion. Two reports attempted to list the great number of functional components, providing many examples of food having health-promoting properties ( (Hasler, 2000) , www.eatright.org). Broccoli, carrots, or tomatoes could be considered functional foods since they are rich in well-recognized physiologically active components such as, respectively, sulforaphane, beta carotene, and lycopene. More generally speaking, increased consumption of fruits, vegetables or nutrients naturally rich in soluble fibers, such as oat bran, is associated with reduced risk for cancer or coronary heart disease (Cohen et al., 2003) . Similarly, plant-derived sterol and stanol esters and consumption of omega-3 fatty acids mostly originating from fish, have been convincingly described to promote cholesterol reduction and decrease the risk of cardiovascular diseases (FDA Report, 2000) .
Finally, fermented-dairy products containing probiotics have also been shown to improve gastro-intestinal health (Sanders and Huis in't Veld, 1999) , notably by modulating the endogenous microflora.
III.2.c : Probiotics.
Probiotics are defined as "microorganisms which upon ingestion in certain number exert health-benefits beyond inherent general nutrition" (Guarner and Schaafsma, 1998) . Probiotic bacteria, intrinsically GRAS (generally recognized as safe) microorganisms, are mainly belonging to the lactic acid bacteria (LAB) family, and are well known to exert beneficial effects in human or animal health.
First, positive effects of LAB have been reported on intestinal functions. The more substantiated effect concerns the improvement on the digestion of lactose (Kolars et al., 1984) . Probiotics have also a stimulatory effect on the colonic reabsorption of water and sodium, via short chain fatty acids, particularly butyrate, along with that of calcium, magnesium, iron and zinc (Scholz-Ahrens et al., 2001) .
Certain strains of bacteria act directly on bile acids through Bile Salt Hydrolase (BSH) activity . Most of the Lactobacillus isolates from human and dairy products possess genes encoding BSH activities (cbsH) and also conjugated bile salt transporters (cbsT1, cbsT2) (Elkins et al., 2001; Elkins and Savage, 2003) . Control of cholesterol through oral live bacterial cell-therapy is based on the demonstration that certain natural lactobacilli can significantly lower serum cholesterol due to BSH activities (De Smet et al., 1994; Anderson and Gilliland, 1999; Taranto et al., 2000) . More recently, Jones et al. (2004) showed the potential of artificial cell microencapsulated genetically engineered Lactobacillus plantarum for bile acids deconjugation to lower cholesterol. Animal studies have confirmed the in vivo cholesterol-lowering effects of selected probiotic strains (Chiu et al., 2005) . Milk diets containing Bifidobacterium have been shown to improve serum lipids in rats as well as in humans with moderate hypercholesterolemia, suggesting a potential use of probiotics in lowering serum cholesterol (Roller, 2004) . Same type of study performed with Bacillus polyfermenticus in rats fed with high fat and high cholesterol diet showed significant health benefits occurring via the modulation of physiologic functions including various arthrogenic lipid profiles and antioxidants in hypercholestrolemia (Paik, 2005) . Moreover, Bleau et al. (2005) recently suggested that selected lactobacilli isolates could reduce Th1-mediated mucosal inflammation by reducing leptin release. Only few human nutritional studies have been designed to assess the effect of probiotics consumption on the composition of the intestinal microbiota. The availability of the genome sequences and post-genomics tools regarding such microorganisms, is opening new issues to investigate the functions of these bacteria in the gut. Using such approach, we recently FIGURE 3. F FIGURE 3. F FIGURE 3. F FIGURE 3. F FIGURE 3. Factors inv actors inv actors inv actors inv actors involv olv olv olv olved in the r ed in the r ed in the r ed in the r ed in the regulation of genes egulation of genes egulation of genes egulation of genes egulation of genes devoted to the control of nutrition state. devoted to the control of nutrition state. devoted to the control of nutrition state. devoted to the control of nutrition state. devoted to the control of nutrition state. participated to the identification of genes of Lactobacillus plantarum whose expression was induced during passage of these bacteria through the gastrointestinal tract. Interestingly, 9 of these 72 genes encode sugar-related functions, whereas others are involved in acquisition and synthesis of amino acids, nucleotides, cofactors and vitamins (Bron, 2004) .
In addition, regular intake of probiotic bacteria contributes to immune homeostasis by altering microbial balance or by interacting with the gut immune system, explaining their potential effect in gastro-intestinal diseases. Probiotics have proven benefits in treatment or prevention of certain type of diarrhea (Arvola et al., 1999) , inflammatory bowel diseases (Gionchetti et al., 2000; Fedorak and Madsen, 2004) , some cancers (Takahashi et al., 2001) , food allergy and atopic eczema in children (Kalliomaki et al., 2001) . These beneficial effects can be exerted through different means, such as production of anti-microbial metabolites, competitive exclusion of enteric pathogens, or neutralization of dietary carcinogens.
The protective effects of probiotics could also be explained by their role in the modulation of mucosal immune responses. Indeed we, and others, showed that probiotics present distinct strainspecific immunomodulatory capacities in vitro (Hessle et al., 1999; Maassen et al., 2000; Mercenier et al., 2004) which can be closely correlated with their in vivo anti-inflammatory potential. Interestingly, the anti-inflammatory effects of lactobacilli observed after either oral or systemic administration (Foligne et al., 2005; Sheil et al., 2004) , suggest that the protective mechanisms might involve regulatory-cell populations. Similarly, recent studies reported that a defined probiotic mixture ameliorates murine colitis by inducing regulatory-T cells (Di Giancinto et al., 2005) and we recently showed that selected strains are able to induce tolerogenic dendritic cells.
Finally, probiotics, thanks to their GRAS characteristics associated with their high resistance to the gastric barrier, have been genetically engineered as tools for the delivery of antigens or therapeutic molecules (Robinson et al., 1997; Steidler et al., 2000; Grangette et al., 2001 ). Nevertheless and obviously, there are many scientific, political and social barriers to allow the introduction of such genetically modified organisms.
Changing lifestyles and dietary patterns over the last 20 years have conspired to increase a number of imbalances. Factors such as advanced age, diabetes, overweight and obesity are considered as risk factors for many diseases. As we evoked above, the combined supplementation of bioactive fibers and probiotics to our diet, could decrease several of these risk factors (Roberfroid, 2000; Bengmark, 2005) .
Thereby, in the field of nutritional science, the current challenge is to supply fundamental and concrete findings to provide efficient and safe strains to consumers (Gorbach, 2002) . In parallel, functional food legislations are being organized worldwide and a special issue recently published (Bagchi, 2006) provides a sequential description of the main regulatory rules. In the United States, the Food and Drug Administration's (FDA) involvement with functional foods expanded in recent years, however, the regulation concerning this type of nutrient and their associated health-claims remains confused (Bagchi, 2006) . Similarly in Japan, the Foods for Specified Health Uses (FOSHU) and in Europe, the International Life Sciences Institute (ILSI, http://europe.ilsi.org/passclaim) have defined the general principles and requirements of food laws. The PASSCLAIM document delivers criteria to assess the scientific support for claims on foods (Aggett, 2005) .
A better understanding of how diet influences individual's genetic potential, overall performance and susceptibility to disease together with a general legislation regulating the use of both dietary supplements and functional foods, will have enormous implications for our society (Milner, 2000) .
. Ov . Ov . Ov . Overall conclusion. erall conclusion. erall conclusion. erall conclusion. erall conclusion.
In this review, we attempted to summarize selected aspects of the regulation of energy homeostasis. Since obesity and its numerous related-disorders are now harmfully blowing up in our industrialized societies, identification and deciphering of the main actors controlling food intake turn out to be an urgent priority considering their enormous toll on human health.
We mainly took into consideration the links existing between the so-to-speak "brains" (i.e. the central nervous system and the enteric nervous system) and the white adipose tissue emphasizing both genes and nutrition (Figure 3) . First, we reported how the formation and functionality of adipose cells is strongly modulated by our diet, taking as examples the extreme cases of calorie restriction and diet-induced obesity both regulating the expression of key genes controlling the adipogenesis process, like PPAR-γ.
Second, we described where and how the central nervous system integrates peripheral signals from the adipose tissue and/or the gastro-intestinal tract according to the nutritional status. We showed that adipocyte-or enteric-derived signals, such as respectively leptin or ghrelin, target the brain in order to ensure a suitable response to any nutritional challenge. Once again, we gave examples of hypothalamic genes highly responsive to nutrient variations.
Last, after a short description of the intestinal commensal flora ranging from its composition to its importance in immune surveillance, we enlarged on how nutrition modified this perfectly well balanced ecosystem. Finally, since consumers worldwide become more health conscious, we end up this third part by presenting the general aspects on functional food and the current claims and perspectives. To conclude, with this review we aimed to help rounding out the picture of how nutrition impacts energy homeostasis.
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